1. Panels
  2. Intellectual disability
  3. ADCY5
Genes in panel
Prev Next
Regions in panel
Prev Next

Intellectual disability

Gene: ADCY5

Amber List (moderate evidence)
ADCY5 (adenylate cyclase 5)
EnsemblGeneIds (GRCh38): ENSG00000173175
EnsemblGeneIds (GRCh37): ENSG00000173175
OMIM: 600293, Gene2Phenotype
ADCY5 is in 11 panels

8 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

I don't know

Comment on list classification: There are patients from two different families reported with biallelic ADCY5 variants and severe intellectual disability. Hence, the MOI and rating have been updated to 'BIALLELIC, autosomal or pseudoautosomal' and amber respectively.
Created: 6 Oct 2025, 9:23 a.m. | Last Modified: 6 Oct 2025, 9:25 a.m.
Panel Version: 9.113
Comment on phenotypes: Biallelic variants in ADCY5 gene has been associated with 'Neurodevelopmental disorder with hyperkinetic movements and dyskinesia' phenotype in OMIM (MIM #619651, OMIM accessed on 06 October 2025).
Created: 6 Oct 2025, 9:16 a.m. | Last Modified: 6 Oct 2025, 9:16 a.m.
Panel Version: 9.109
PMID:33704598 (2021) reported two siblings of Japanese descent with severe intellectual disability (ID), motor disability, dystonic movement and growth failure. They were identified with a homozygous missense variant in ADCY5 gene (p.Arg1238Trp).

PMID:34631954 (2021) reported three siblings of Egyptian descent with the same complex neurological disorder characterised by severe ID, movement disorder including dystonia, and growth failure. They were identified with a homozygous splice site variant in ADCY5 gene (c.897+1G>T).
Created: 6 Oct 2025, 9:14 a.m. | Last Modified: 6 Oct 2025, 9:14 a.m.
Panel Version: 9.108

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Neurodevelopmental disorder with hyperkinetic movements and dyskinesia, OMIM:619651; neurodevelopmental disorder with hyperkinetic movements and dyskinesia, MONDO:0859211

Publications

Created: 6 Oct 2025, 9:14 a.m.
Last Modified: 6 Oct 2025, 9:25 a.m.
Panel version: 9.108

Arina Puzriakova (Genomics England Curator)

Following discussion with the clinical team, this gene has been demoted from Amber to Red, in accordance with the external review by Zornitza Stark
Created: 14 Aug 2020, 1:58 p.m. | Last Modified: 14 Aug 2020, 1:58 p.m.
Panel Version: 3.249
Created: 14 Aug 2020, 1:58 p.m.
Last Modified: 14 Aug 2020, 1:58 p.m.
Panel version: 3.249

Zornitza Stark (Australian Genomics)

Red List (low evidence)

Variants in this gene cause a movement disorder, intellectual disability is not typically a feature.
Created: 27 Jan 2020, 5:09 a.m. | Last Modified: 27 Jan 2020, 5:09 a.m.
Panel Version: 3.0

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Dyskinesia, familial, with facial myokymia, MIM#606703

Created: 27 Jan 2020, 5:09 a.m.
Last Modified: 27 Jan 2020, 5:09 a.m.
Panel version: 3.0

Ellen McDonagh (Genomics England Curator)

Comment when marking as ready: Updated based on the latest reviews displayed here from the Intellectual disability update Oct 2017 panel.
Created: 29 Nov 2017, 3:50 p.m.
Created: 29 Nov 2017, 3:50 p.m.

Panel version: 1.471

Helen Brittain (Genomics England Curator)

Comment on list classification: Phenotype is primarily a movement disorder which has secondary effects on ambulation and in some cases, speech. There is no clear phenotypic link with moderate, or greater, learning difficulty. More appropriate for the early onset dystonia panel (already green there). Advise against ID panel on the phenotype reported at present.
Created: 13 Nov 2017, 1:57 p.m.
Created: 13 Nov 2017, 1:57 p.m.

Panel version: Imported from Intellectual disability update Oct 2017 panel version 0.74

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

2 variants in the same codon in 5 unrelated cases of Dyskinesia, familial, with facial myokymia (mim 606703), with language delay
Created: 31 Oct 2017, 9:57 a.m.

Publications

Created: 31 Oct 2017, 9:57 a.m.

Panel version: Imported from Intellectual disability update Oct 2017 panel version 0.5

BRIDGE consortium (NIHRBR-RD)

Green List (high evidence)

This is a pertinent gene from the NIHR BioResource - Rare Diseases Study (NIHRBR-RD) BRIDGE Study : SPEED (Specialist Pathology: Evaluating Exomes in Diagnostics) which covers epilepsies, movement and microcephaly disorders, this gene is on the SPEED_NEURO_20170705 gene list. Evidences used for SPEED NEURO gene list: in_manual . Main mutation mechanism : GOF
Created: 27 Jul 2017, 5 p.m.
Evidences key, gene present in following gene lists and main mutation mechanism : sfari_20150206; neuro_20160418_strict; GOF. This is a pertinent gene from the BRIDGE Study : SPEED (Specialist Pathology: Evaluating Exomes in Diagnostics) which covers epilepsies, movement and microcephaly disorders, this gene comes from the SPEED_NEURO_v3.0_20170404 gene list. The following experts from the BRIDGE consortium NIHRBR-RD contributed to this panel: - Professor F. Lucy Raymond, Cambridge Institute for Medical Research, University of Cambridge - Manju Kurian, Paediatric neurologist, Great Ormond Street Hosptial - Keren Carss, NIHR BioResource - Rare Diseases, Cambridge University Hospitals NHS Foundation Trust - Alba Sanchis-Juan, NIHR BioResource - Rare Diseases, Cambridge University Hospitals NHS Foundation Trust - Marie Erwood NIHR BioResource - Rare Diseases, Cambridge University Hospitals NHS Foundation Trust - Louise Daugherty, NIHR BioResource - Rare Diseases, Cambridge University Hospitals NHS Foundation Trust
Created: 19 Jul 2017, 11:55 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Publications

  • Manual assessment of Genes of interest from literature searches and personal communication

Mode of pathogenicity
Other

Created: 2 Aug 2017, 1:54 p.m.

Panel version: 1.354

Louise Daugherty (Genomics England Curator)

Comment on list classification: This gene is from an expert list and needs further assessment by the Genomics England curation team to access inclusion and pertinence to this panel.
Created: 19 Jul 2017, 5:14 p.m.
Created: 19 Jul 2017, 5:14 p.m.

Panel version: 1.183

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
Phenotypes
  • Neurodevelopmental disorder with hyperkinetic movements and dyskinesia, OMIM:619651
  • neurodevelopmental disorder with hyperkinetic movements and dyskinesia, MONDO:0859211
OMIM
600293
Clinvar variants
Variants in ADCY5
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

6 Oct 2025, Gel status: 2

Entity classified by Genomics England curator

Achchuthan Shanmugasundram (Genomics England Curator)

Gene: adcy5 has been classified as Amber List (Moderate Evidence).

6 Oct 2025, Gel status: 1

Set mode of inheritance

Achchuthan Shanmugasundram (Genomics England Curator)

Mode of inheritance for gene: ADCY5 was changed from MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown to BIALLELIC, autosomal or pseudoautosomal

6 Oct 2025, Gel status: 1

Set mode of pathogenicity

Achchuthan Shanmugasundram (Genomics England Curator)

Mode of pathogenicity for gene: ADCY5 was changed from Other - please provide details in the comments to None

6 Oct 2025, Gel status: 1

Set publications

Achchuthan Shanmugasundram (Genomics England Curator)

Publications for gene: ADCY5 were set to 28511835

6 Oct 2025, Gel status: 1

Set Phenotypes

Achchuthan Shanmugasundram (Genomics England Curator)

Phenotypes for gene: ADCY5 were changed from Dyskinesia, familial, with facial myokymia, 606703 to Neurodevelopmental disorder with hyperkinetic movements and dyskinesia, OMIM:619651; neurodevelopmental disorder with hyperkinetic movements and dyskinesia, MONDO:0859211

25 Sep 2020, Gel status: 1

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: adcy5 has been classified as Red List (Low Evidence).

12 Mar 2018, Gel status: 2

Panel promoted to version 2.0

Ellen McDonagh (Genomics England Curator)

12.03.2018: Due to major updates completed (Phase 1, 2 and 3), this panel was promoted to Version 2 in order to reflect the major updates since November 2017 which have resulted in reviews for 836 genes added by Genomics England Curators and the Clinical Team, 130 new Green genes added to the interpretation pipeline (from 751 to 881 Green genes), and the gene total has increased from 1879 to 1927.

29 Nov 2017, Gel status: 2

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

29 Nov 2017, Gel status: 2

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for gene ADCY5 was set to ['28511835']

19 Jul 2017, Gel status: 2

Gene classified by Genomics England curator

Louise Daugherty (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

19 Jul 2017, Gel status: 0

Added New Source

BRIDGE consortium (NIHRBR-RD)

ADCY5 was added to Intellectual disabilitypanel. Sources: BRIDGE study SPEED NEURO Tier1 Gene

19 Jul 2017, Gel status: 0

Created

BRIDGE consortium (NIHRBR-RD)

ADCY5 was created by BRIDGE